How much would you pay to know if your baby was in pain?

Painchek, the world's first smartphone pain assessment app now has prototypes in development for the third stage of its business, infant

pain monitoring, according to CEO Phillip Daffas.

The app, which has regulatory clearance in Australia and Europe, uses a smartphone to detect pain levels through facial recognition technology and targets dementia, aged care and soon, the infant market.

Daffas told InsideMarket.net's Editor Phil Carey, that the enterprise version of the app, which has several revenue generating contracts in place, is embedding well into the dementia carer segment.             play video 0.53

Painchek has a total of 3 business channels.

• Enterprise 

• Consumer

• Infant

The next phase of the Painchek business plan is the consumer version of the app, due out mid 2018.  

"There are 200,00 thousand dementia sufferers in aged care facilities now, so we estimate the number still living at home could be 400,00."

Unlike the enterprise app, this version will be available to consumers through app stores for professionals and non professional carers, initially in Australia and then Europe. play video 0.28

Daffas said he believes technology like Painchek is the start of a trend in health care which will see more people taking control of their care.

He sites products like Reckitt Benckiser's FeverSmart baby temperature monitor as an example although denied having any discussions with the company to do a joint marketing play. play video 0.28

The infant version of the Painchek app is due to roll out in late 2018 and will probably follow the same track as the consumer version, starting in Australia and then onto other regions.

That will almost certainly include North America.

Painchek is hoping to get clarity on the classification class from the US FDA and regulatory approval for its device by the end of 2018.

No news yet,  but as devices, compared to pharmaceuticals, are considered easier to get approval for, the announcement may not be too far off. 

When that happens, the infant app could be a major money spinner for Painchek and far bigger than the enterprise and consumer sectors combined. play video 0.38

UNCUT INTERVIEW 

Insidemarket does not offer any financial or investment advice. investing in technology stocks can be extremely risky. you should seek the advice of a registered financial adviser before investing.